# Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

> **NCT04601038** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 52 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Alzheimer Disease
- Memory Impairment

## Interventions

- **DRUG:** CORT108297
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04601038
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-28
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-01-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04601038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04601038, "Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04601038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*